IRIS Accounts Production v23.3.1.45 10480752 Board of Directors 1.12.22 30.11.23 30.11.23 false true false false false 13507 2021 2287 23389 16858 7861 1064 13507 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh104807522022-11-30104807522023-11-30104807522022-12-012023-11-30104807522021-11-30104807522021-12-012022-11-30104807522022-11-3010480752ns10:Originalns15:EnglandWales2022-12-012023-11-3010480752ns14:PoundSterlingns10:Original2022-12-012023-11-3010480752ns10:Originalns10:Director12022-12-012023-11-3010480752ns10:Original2022-12-012023-11-3010480752ns10:Original2023-11-3010480752ns10:Originalns10:PrivateLimitedCompanyLtd2022-12-012023-11-3010480752ns10:Originalns10:Micro-entities2022-12-012023-11-3010480752ns10:Originalns10:AuditExempt-NoAccountantsReport2022-12-012023-11-3010480752ns10:Originalns10:FullAccounts2022-12-012023-11-3010480752ns10:Original42ns10:Director22022-11-3010480752ns10:Original42ns10:Director22021-11-3010480752ns10:Original42ns10:Director22022-12-012023-11-3010480752ns10:Original42ns10:Director22021-12-012022-11-3010480752ns10:Original42ns10:Director22023-11-3010480752ns10:Original42ns10:Director22022-11-3010480752ns10:Originalns10:Director22022-12-012023-11-3010480752ns10:Originalns10:RegisteredOffice2022-12-012023-11-3010480752ns10:Original2022-11-3010480752ns10:Originalns5:CurrentFinancialInstruments2023-11-3010480752ns10:Originalns5:CurrentFinancialInstruments2022-11-3010480752ns10:Original2021-12-012022-11-3010480752ns10:Original1ns10:Director12022-11-3010480752ns10:Original1ns10:Director12021-11-3010480752ns10:Original1ns10:Director12022-12-012023-11-3010480752ns10:Original1ns10:Director12021-12-012022-11-3010480752ns10:Original1ns10:Director12023-11-3010480752ns10:Original1ns10:Director12022-11-30
REGISTERED NUMBER: 10480752 (England and Wales)







UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 NOVEMBER 2023

FOR

ANAESTHESIA MANCHESTER LIMITED

ANAESTHESIA MANCHESTER LIMITED (BY SHARES) (REGISTERED NUMBER: 10480752)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023




Page

Company Information 1

Balance Sheet 2


ANAESTHESIA MANCHESTER LIMITED (BY SHARES)

COMPANY INFORMATION
FOR THE YEAR ENDED 30 NOVEMBER 2023







DIRECTORS: Mr S Maguire
Dr L Campbell





REGISTERED OFFICE: Rex Buildings
Alderley Road
Wilmslow
Cheshire
SK9 1HY





REGISTERED NUMBER: 10480752 (England and Wales)

ANAESTHESIA MANCHESTER LIMITED (BY SHARES) (REGISTERED NUMBER: 10480752)

BALANCE SHEET
30 NOVEMBER 2023

2023 2022
£    £    £    £   
FIXED ASSETS 53,689 71,200

CURRENT ASSETS 110,778 57,487

CREDITORS
Amounts falling due within one year (14,888 ) (2,366 )
NET CURRENT ASSETS 95,890 55,121
TOTAL ASSETS LESS CURRENT
LIABILITIES

149,579

126,321

CAPITAL AND RESERVES 149,579 126,321

NOTES TO THE FINANCIAL STATEMENTS

1. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 4 (2022 - 2 ) .

2. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30 November 2023 and 30 November 2022:

2023 2022
£    £   
Mr S Maguire and Dr L Campbell
Balance outstanding at start of year 13,507 (2,021 )
Amounts advanced 2,287 23,389
Amounts repaid (16,858 ) (7,861 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (1,064 ) 13,507



ANAESTHESIA MANCHESTER LIMITED (BY SHARES) (REGISTERED NUMBER: 10480752)

BALANCE SHEET - continued
30 NOVEMBER 2023


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 13 March 2024 and were signed on its behalf by:





Mr S Maguire - Director